SC restrains government from taking a call on 15 banned FDC drugs

The apex court in December referred the issue of 329 FDC drugs to the DTAB for a fresh review before recommending any action.

The panel constituted by the government pursuant the apex court’s December 15, 2017 judgment reviewed the safety, efficacy and therapeutic justification of these FDC drugs, which were banned in 2015, along with those that had been banned before 1988.